Back to search
FDAFDA · Food and drugs·Recall number D-0026-2019

Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30

Published October 17, 2018 · Recall initiated: September 10, 2018

Summary

FDA records drug Class II recall D-0026-2019, published October 17, 2018 and initiated September 10, 2018. Recalling firm: Takeda Development Center Americas, Inc.; Status: Terminated; Reported quantity: 7,248 bottles; Lot: Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Takeda Development Center Americas, Inc.
Distributor
AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico
Lot
Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30 recalled?

Yes. FDA published recall D-0026-2019 on October 17, 2018. Reported hazard: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter